173 related articles for article (PubMed ID: 29658613)
1. Detection of survivin expression in bladder cancer and renal cell carcinoma using specific monoclonal antibodies.
Chen D; Xu J; Zhang Q
Oncol Rep; 2018 Jun; 39(6):2817-2828. PubMed ID: 29658613
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
3. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of survivin/glyceraldehyde-3-phosphate dehydrogenase ratio in urine exfoliated cells for the detection of bladder tumor].
Sakamoto Y; Nishioka J; Noma K; Yasuda K; Nakatani K; Kise H; Sugimura Y; Nobori T
Rinsho Byori; 2011 May; 59(5):446-51. PubMed ID: 21706857
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
[TBL] [Abstract][Full Text] [Related]
6. Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile Cancer.
Wan YP; Xi M; He HC; Wan S; Hua W; Zen ZC; Liu YL; Zhou YL; Mo RJ; Zhuo YJ; Luo HW; Jiang FN; Zhong WD
Oncol Res Treat; 2017; 40(1-2):15-20. PubMed ID: 28118628
[TBL] [Abstract][Full Text] [Related]
7. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
[TBL] [Abstract][Full Text] [Related]
9. Urine detection of survivin and diagnosis of bladder cancer.
Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
[TBL] [Abstract][Full Text] [Related]
10. Tumor M2 pyruvate kinase in plasma of patients with urological tumors.
Roigas J; Schulze G; Raytarowski S; Jung K; Schnorr D; Loening SA
Tumour Biol; 2001; 22(5):282-5. PubMed ID: 11553857
[TBL] [Abstract][Full Text] [Related]
11. The expression and significance of survivin mRNA in urinary bladder carcinomas.
Wang H; Xi X; Kong X; Huang G; Ge G
J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
[TBL] [Abstract][Full Text] [Related]
12. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].
Jiang LL; Xie MM; Wang XR; Zhao Y; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3520-2. PubMed ID: 24521893
[TBL] [Abstract][Full Text] [Related]
14. Tissue specific expression and serum levels of human tissue factor in patients with urological cancer.
Förster Y; Meye A; Albrecht S; Kotzsch M; Füssel S; Wirth MP; Schwenzer B
Cancer Lett; 2003 Apr; 193(1):65-73. PubMed ID: 12691825
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations of adenomatous polyposis coli (APC), retinoic acid receptor beta (RARβ) and survivin genes in tumor tissues and voided urine of bladder cancer patients.
Berrada N; Amzazi S; Ameziane El Hassani R; Benbacer L; El Mzibri M; Khyatti M; Chafiki J; Abbar M; Al Bouzidi A; Ameur A; Attaleb M
Cell Mol Biol (Noisy-le-grand); 2012 Sep; Suppl.58():OL1744-51. PubMed ID: 22992440
[TBL] [Abstract][Full Text] [Related]
17. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
[TBL] [Abstract][Full Text] [Related]
18. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
[TBL] [Abstract][Full Text] [Related]
19. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
[TBL] [Abstract][Full Text] [Related]
20. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
